Gefitinib Stada

Gefitinib Stada is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Stada is primarily used in the treatment of non-small cell lung cancer (NSCLC). It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced or metastatic NSCLC that has specific EGFR mutations.

Common effects of Gefitinib Stada may include skin rash, diarrhea, and nausea. Some users may also experience fatigue or loss of appetite. These effects can vary from person to person and are not exhaustive. Always consult a healthcare provider for personalized advice.

Gefitinib Stada should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication.

Gefitinib Stada may interact with other medications, including certain antibiotics, antifungals, and seizure medications. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect the metabolism of Gefitinib.